pharmaceutical industry

Actavis, Formerly Watson, Sees 2013 Profit Growth

Novartis CEO Tempers Talk of Roche Stake Sale

Baxter Profit Higher; Sales Seen Rising 10% in 2013

Amgen 2013 Revenue Forecast Tops Street Estimates

Abbott Results Bode Well for Spun-off AbbVie

Dr. Joerg Reinhardt to Leave Bayer HealthCare

Novartis Expects Sales to Grow from 2014

J&J Profit Tops Forecast, Mulls Sale of Diagnostic Unit

Rx-360 Elects New Officers and Board Members

Evidence Grows for Narcolepsy Link to GlaxoSmithKline's Swine Flu Shot

BASF Clears Hurdle to Bag Norway's Pronova

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

Roche Says US Allows it to Tap Adult Tamiflu Reserves

BASF's Bid for Fish-oil Maker Pronova on Knife Edge

Drug Industry Bets on New Blockbusters in 2013

DSM Announces License Agreement with Amgen

BASF Increases Cash Offer for Pronova BioPharma

AstraZeneca's New CEO Removes R&D, Commercial Heads

Forest Posts Loss as Antidepressant Sales Plummet

Roche Hires U.S. Academic to Revitalise Research Unit

Merck Steers Doctors Away from HDL Cholesterol Drug

Swiss Health Insurer Makes Claim Against Bayer Over Yasmin Pill

BioMarin Won't Sell Itself for 25-30% Premium

Amgen Trims 2012 EPS Estimate, Citing R&D Tax Credit Delay

Shire Adds to Genetic Disorder Drugs with U.S. Deal

China to Cut Prices of More than 400 Drugs from February

AMRI Promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

Sartorius, Lonza Announce Collboration on Cell Culture Media

Actelion Sticks to Forecast for Return to Growth from 2014

Celgene Issues 2013, Long-term Forecasts

Sanofi Appoints Dr. Gary J. Nabel as Chairman of the Strategic Development and Scientific Advisory Council

Vivus Obesity Pill Prescriptions Jump 68%

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

Italy's Philogen Signs Drug License Deal with Pfizer

Top-Selling Drugs for Ultra-Rare Diseases

204 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

McKinsey & Company Inc.

BioCampus Straubing

Press'n'Relations GmbH Niederlassung Berlin

HAS Healthcare Advanced Synthesis SA

PolarixPartner GmbH

Yokogawa Deutschland GmbH

Evonik Industries AG

Camelot Management Consultants AG

Fraunhofer SCS

ARC Advisory Group GmbH & Co KG

PureTech Systems

Arthur D. Little

Concept Heidelberg

gempex GmbH – THE GMP-EXPERT

Isomorphic Labs

CONTINUUS Pharmaceuticals, Inc.

LLamasoft Deutschland GmbH

The Scott Partnership

BearingPoint GmbH

CPA Chemical Pharmac. Ass.

trans-o-flex Express GmbH

Dr. Spiggelkötter Knowledge and Support

Camelot Management Consultants AG

Cedarburg Hauser Pharmaceuticals

Siemens AG Industry Automation Division

CatSci Ltd.

Germany Trade & Invest

EquipNet Inc.

Miebach Consulting GmbH

Dechema e.V.

ISPE D/A/CH e.V.

EvaluatePharma

International Society for Pharmaceutical Engineering (ISPE)

Roland Berger GmbH

WeylChem International GmbH

SchüllerConsulting

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

Novo Nordisk A/S